Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT06807281

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Cahaba Dermatology & Skin Health Center Birmingham, Alabama, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Investigational Drug Service - Rady Childrens Hospital-San Diego San Diego, California, United States
  • University of California, San Diego/ Rady Children's Hospital - San Diego San Diego, California, United States
View all 39 locations
View Trial Details
Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

NCT06246916

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 112 locations
View Trial Details
Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT06393374

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Infirmary Cancer Care ( Site 0001) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers-Research ( Site 0054) Chandler, Arizona, United States
  • MemorialCare Orange Coast Medical Center ( Site 9501) Fountain Valley, California, United States
  • Scripps Cancer Center ( Site 0052) La Jolla, California, United States
View all 311 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +24 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07607964

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Pinnacle Research Group /ID# 278677 Anniston, Alabama, United States
  • Solace Research /ID# 279155 Tustin, California, United States
  • Clinical Research Of West Florida - Phase I Unit /ID# 279292 Clearwater, Florida, United States
  • Finlay Medical Research - Greenacres /ID# 278380 Greenacres City, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 91 locations
View Trial Details
Recruiting

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

NCT07438496

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • David S Hallegua MD A Professional Corporation Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis Hemet, California, United States
  • Advanced Medical Research La Palma, California, United States
View all 260 locations
View Trial Details

Related conditions